229 related articles for article (PubMed ID: 28334704)
21. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.
Weinstein LS; Shenker A; Gejman PV; Merino MJ; Friedman E; Spiegel AM
N Engl J Med; 1991 Dec; 325(24):1688-95. PubMed ID: 1944469
[TBL] [Abstract][Full Text] [Related]
22. Fibrous Dysplasia/McCune-Albright Syndrome: Clinical and Translational Perspectives.
Robinson C; Collins MT; Boyce AM
Curr Osteoporos Rep; 2016 Oct; 14(5):178-86. PubMed ID: 27492469
[TBL] [Abstract][Full Text] [Related]
23. McCune-Albright syndrome with acromegaly and fibrous dysplasia associated with the GNAS gene mutation identified by sensitive PNA-clamping method.
Imanaka M; Iida K; Nishizawa H; Fukuoka H; Takeno R; Takahashi K; Kaji H; Takahashi Y; Okimura Y; Kaji H; Imanishi Y; Chihara K
Intern Med; 2007; 46(18):1577-83. PubMed ID: 17878646
[TBL] [Abstract][Full Text] [Related]
24. A novel technique based on a PNA hybridization probe and FRET principle for quantification of mutant genotype in fibrous dysplasia/McCune-Albright syndrome.
Karadag A; Riminucci M; Bianco P; Cherman N; Kuznetsov SA; Nguyen N; Collins MT; Robey PG; Fisher LW
Nucleic Acids Res; 2004 Apr; 32(7):e63. PubMed ID: 15096559
[TBL] [Abstract][Full Text] [Related]
25. Fibrous Dysplasia of Bone and McCune-Albright Syndrome: A Bench to Bedside Review.
Hartley I; Zhadina M; Collins MT; Boyce AM
Calcif Tissue Int; 2019 May; 104(5):517-529. PubMed ID: 31037426
[TBL] [Abstract][Full Text] [Related]
26. Searching for Arg201 mutations in the GNAS1 gene in Italian patients with McCune-Albright syndrome.
de Sanctis L; Romagnolo D; Greggio N; Genitori L; Lala R; de Sanctis C
J Pediatr Endocrinol Metab; 2002; 15 Suppl 3():883-9. PubMed ID: 12199346
[TBL] [Abstract][Full Text] [Related]
27. Hepatobiliary and Pancreatic neoplasms in patients with McCune-Albright syndrome.
Gaujoux S; Salenave S; Ronot M; Rangheard AS; Cros J; Belghiti J; Sauvanet A; Ruszniewski P; Chanson P
J Clin Endocrinol Metab; 2014 Jan; 99(1):E97-101. PubMed ID: 24170100
[TBL] [Abstract][Full Text] [Related]
28. McCune Albright syndrome and bilateral adrenal hyperplasia: the GNAS mutation may only be present in adrenal tissue.
Angelousi A; Fencl F; Faucz FR; Malikova J; Sumnik Z; Lebl J; Stratakis CA
Hormones (Athens); 2015; 14(3):447-50. PubMed ID: 26188235
[TBL] [Abstract][Full Text] [Related]
29. McCune Albright syndrome is a genetic predisposition to intraductal papillary and mucinous neoplasms of the pancreas associated pancreatic cancer in relation with GNAS somatic mutation - a case report.
Gaujoux S; Pasmant E; Silve C; Mehsen-Cetre N; Coriat R; Rouquette A; Douset B; Prat F; Leroy K
Medicine (Baltimore); 2019 Dec; 98(50):e18102. PubMed ID: 31852070
[TBL] [Abstract][Full Text] [Related]
30. The role of type 1 and type 2 5'-deiodinase in the pathophysiology of the 3,5,3'-triiodothyronine toxicosis of McCune-Albright syndrome.
Celi FS; Coppotelli G; Chidakel A; Kelly M; Brillante BA; Shawker T; Cherman N; Feuillan PP; Collins MT
J Clin Endocrinol Metab; 2008 Jun; 93(6):2383-9. PubMed ID: 18349068
[TBL] [Abstract][Full Text] [Related]
31. The Clinical Spectrum of McCune-Albright Syndrome and Its Management.
Spencer T; Pan KS; Collins MT; Boyce AM
Horm Res Paediatr; 2019; 92(6):347-356. PubMed ID: 31865341
[TBL] [Abstract][Full Text] [Related]
32. Frequency of GNAS R201H substitution mutation in polyostotic fibrous dysplasia: Pyrosequencing analysis in tissue samples with or without decalcification.
Shin SJ; Lee SJ; Kim SK
Sci Rep; 2017 Jun; 7(1):2836. PubMed ID: 28588314
[TBL] [Abstract][Full Text] [Related]
33. Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone.
Bianco P; Riminucci M; Majolagbe A; Kuznetsov SA; Collins MT; Mankani MH; Corsi A; Bone HG; Wientroub S; Spiegel AM; Fisher LW; Robey PG
J Bone Miner Res; 2000 Jan; 15(1):120-8. PubMed ID: 10646121
[TBL] [Abstract][Full Text] [Related]
34. Genetic diagnosis of multiple affected tissues in a patient with McCune-Albright syndrome.
Zhou J; Sun LH; Cui B; Song HD; Li XY; Ning G; Liu JM
Endocrine; 2007 Apr; 31(2):212-7. PubMed ID: 17873334
[TBL] [Abstract][Full Text] [Related]
35. An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome.
Shenker A; Weinstein LS; Sweet DE; Spiegel AM
J Clin Endocrinol Metab; 1994 Sep; 79(3):750-5. PubMed ID: 8077356
[TBL] [Abstract][Full Text] [Related]
36. McCune-Albright syndrome and disorders due to activating mutations of GNAS1.
Diaz A; Danon M; Crawford J
J Pediatr Endocrinol Metab; 2007 Aug; 20(8):853-80. PubMed ID: 17937059
[TBL] [Abstract][Full Text] [Related]
37. The diagnostic utility of the GNAS mutation in patients with fibrous dysplasia: meta-analysis of 168 sporadic cases.
Lee SE; Lee EH; Park H; Sung JY; Lee HW; Kang SY; Seo S; Kim BH; Lee H; Seo AN; Ahn G; Choi YL
Hum Pathol; 2012 Aug; 43(8):1234-42. PubMed ID: 22245114
[TBL] [Abstract][Full Text] [Related]
38. Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia.
Kobayashi K; Imanishi Y; Koshiyama H; Miyauchi A; Wakasa K; Kawata T; Goto H; Ohashi H; Koyano HM; Mochizuki R; Miki T; Inaba M; Nishizawa Y
Life Sci; 2006 Apr; 78(20):2295-301. PubMed ID: 16337659
[TBL] [Abstract][Full Text] [Related]
39. Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations.
Collins MT; Sarlis NJ; Merino MJ; Monroe J; Crawford SE; Krakoff JA; Guthrie LC; Bonat S; Robey PG; Shenker A
J Clin Endocrinol Metab; 2003 Sep; 88(9):4413-7. PubMed ID: 12970318
[TBL] [Abstract][Full Text] [Related]
40. GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation.
Nault JC; Fabre M; Couchy G; Pilati C; Jeannot E; Tran Van Nhieu J; Saint-Paul MC; De Muret A; Redon MJ; Buffet C; Salenave S; Balabaud C; Prevot S; Labrune P; Bioulac-Sage P; Scoazec JY; Chanson P; Zucman-Rossi J
J Hepatol; 2012 Jan; 56(1):184-91. PubMed ID: 21835143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]